The Indian API (bulk drugs) manufacturing industry is estimated to have touched USD4.10 billion by 2007, growing at

CAGR of 18.81% during 2003-07. India ranks fourth in terms of volume among the top 15 drug manufacturing countries.

Cygnus releases the latest version of the Indian Bulk Drugs Industry Insight to capture the present domestic market

scenario, along with the major players and their key financials

Key Findings & Highlights

-  The global pharmaceutical market was valued at USD712 billion in 2007.
-  According to IMS Health, treatment costs per day declined by 20-40% in 2007 in therapy
Areas
- Generics continued to replace branded prescriptions in the major therapeutic classes,
increasing their share of total dispensed prescriptions to 67.3 %.
- In 2007, North America, which accounts for 45.9% of global pharmaceutical sales, grew by  4.2% to USD304.5 billion
- The market size for the global bulk drugs was USD77.32 billion in 2005 and was
estimated to be USD92.21 billion in 2007
- Indian companies have the distinction of developing cost-effective technologies for
manufacturing bulk drugs and intermediates that conform to global standards.

Reasons to Buy

- Understand the global bulk drug market scenario
- Know investment opportunities according to the trend analysis
- Reveals the demand analysis of the bulk drugs industry
- Assess the cost effective technologies for manufacturing bulk drugs

To know about or to buy a copy of this report feel free to contact us at
http://www.bharatbook.com/detail.asp?id=90918&rt=Indian-Bulk-Drugs-Report.html
OR
Bharat Book Bureau
Tel: +91 22 27578668
Fax: +91 22 27579131
Email: info@bharatbook.com
Website: www.bharatbook.com
Blog: http://bharatbookresearch.blogspot.com
Follow us on twitter: http://twitter.com/3bbharatbook